From the moment that announcement was released, I've been pondering in the back of my mind what could possibly be the reason Imugene terminates the relationship "Effective Immediately" with no real reason. Could it be IMU have signed a MOU with BP, and one of the pre conditions of the deal is to terminate their relationship with ALA as it could be an overlap or conflict of interest with one of their own products? Certainly seems plausible. I even think the latest data cut may have been the catalyst for a deal to have been struck. If this is the case, I think we should probably see an announcement to that effect sometime next week. I could be wrong here, but it is certainly not out of the realms of possibility. I like many of you, hope it is the case, and if it is, look out.
It's just my humble opinion. GLTAH
Stockman
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update, page-20
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |